Related Experiment Video
Updated: Mar 13, 2026

10:33
Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
22.0K
Alginate Microbeads for Cell and Protein Delivery
Sami I Somo1,2, Omaditya Khanna3, Eric M Brey4,5
1Department of Biomedical Engineering, Illinois Institute of Technology, 3255 South Dearborn St, Chicago, IL, 60616, USA.
Methods in Molecular Biology (Clifton, N.J.)
|October 15, 2016
Summary
Alginate microbeads offer a versatile platform for encapsulating cells and delivering proteins, particularly for type I diabetes islet cell transplantation. These systems show promise in tissue engineering and regenerative medicine applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Biotechnology
Background:
- Alginate hydrogels are widely utilized in various medical applications due to their biocompatibility and ability to form gels under mild conditions.
- The neutral pH and mild temperature gelation of alginate make it suitable for sensitive biological payloads like cells and proteins.
- Alginate microbeads are a key formulation for advanced drug delivery and tissue engineering scaffolds.
Purpose of the Study:
- To detail methods for cell and protein encapsulation using single-layered and multilayered alginate microbead systems.
- To explore the application of these alginate microbeads for islet encapsulation as a potential therapy for type I diabetes.
- To highlight the broader utility of these microbead systems in tissue engineering and regenerative medicine.
Main Methods:
- Encapsulation of cells within alginate microbeads with a permselective polymer coating.
- Development of multilayer alginate microbead systems for simultaneous cell encapsulation and growth factor delivery.
- Focus on islet encapsulation for type I diabetes treatment.
Main Results:
- Demonstration of two distinct alginate microbead systems: single-layered and multilayered.
- Successful encapsulation of cells and potential for controlled protein delivery.
- Primary application focus on islet encapsulation for type I diabetes.
Conclusions:
- Alginate microbeads, in both single-layered and multilayered configurations, provide a robust platform for cell and protein delivery.
- These systems hold significant potential for treating type I diabetes through islet encapsulation.
- The versatility of alginate microbeads extends to diverse applications in tissue engineering and regenerative medicine.

